Agatolimod
- Generic Name
- Agatolimod
- Drug Type
- Biotech
- CAS Number
- 207623-20-9
- Unique Ingredient Identifier
- 5V336PV3HG
- Background
Agatolimod is under investigation in clinical trial NCT00471471 (Vaccine Therapy in Treating Patients With Recurrent Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery).
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath